Understanding the Complex Rare Disease and Specialty Pharmaceutical Landscape

Donovan Quill, AscellaHealth’s Executive Vice President of Growth and Strategy, describes the unique challenges associated with bringing new specialty and rare disease pharmaceutical products to market and how to increase the chance of success.

To read more, click here.